China develops AI that predicts diseases with a blood test up to 15 years before they occur

Artificial intelligence (AI) continues to revolutionize the health field, and on this occasion, a group of researchers from China has developed A system that allows diseases to be predicted with a surprising anticipation of up to 15 years. This innovative method It is based on a blood test that, thanks to advanced algorithms, is able to detect early signs of various medical conditions, which could represent a major advance in early diagnosis.

The project has been carried out by scientists from Fudan University, who have been working on data collection for over a decade. By studying thousands of blood samples, they have managed to build a predictive model of diseases based on the biochemistry of blood plasma. With this system, it is hoped to be able to accurately diagnose pathologies such as dementia and heart conditions long before the first symptoms appear.

A protein map to predict diseases with AI

To develop this technology, researchers have created the first "Proteome Map of Human Health and Disease«, a detailed record of biomarkers present in the blood that can indicate the risk of suffering from various pathologies. This work has involved the analysis of More than 50.000 blood samples of patients over a period of 14 years, which has allowed identify patterns in the evolution of certain plasma proteins.

In its initial phase, the study focused on analyzing approximately 1.500 proteins present in plasma, of which were detected 11 with a clear relationship with the development of dementia. They subsequently expanded their research by examining nearly 3.000 proteins, which has allowed them to further refine their predictive model and identify risks for hundreds of diseases years in advance.

An affordable test for early prediction of pathologies

One of the main goals of the researchers is to make this innovative technology accessible to the general population. According to Yu Jintai, deputy director of the Research Institute of Fudan University, The cost of this blood test would be between 5 and 10 dollars., which would make it affordable for a large part of the population. Compared to other traditional diagnostic methods, this AI-based system would be significantly more economical.

The team is currently working on the development of a rapid test kit that would allow these analyses to be carried out easily and without the need for expensive laboratory equipment. The intention is that in the future, these types of tests could be as common and accessible as a blood sugar check or a blood pressure measurement.

China and artificial intelligence in the healthcare sector

The use of artificial intelligence in medicine is expanding rapidly in China. In addition to this innovative blood test, Researchers at Hangzhou Liangzhu Laboratory have used AI algorithms in the development of new drugs, achieving reduce drug design time from the usual 15-20 years to just 3-5 years.

These types of advances demonstrate the enormous potential that AI has to transform the healthcare sector, making possible faster diagnoses, more effective treatments and a more personalized medicine. With the development of this new early detection system, China is positioning itself as a benchmark in the integration of artificial intelligence in medicine.

The development of this AI blood analysis technology represents great hope for early detection of diseases. Not only does it increase the chances of effective treatments before symptoms appear, but it also could significantly reduce healthcare costs globally. As it is refined and made more accessible, this advancement It could completely change the way a multitude of pathologies are diagnosed in the future..